GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (NAS:XOMA) » Definitions » E10

XOMA (XOMA Royalty) E10 : $-3.04 (As of Sep. 2024)


View and export this data going back to 1986. Start your Free Trial

What is XOMA Royalty E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

XOMA Royalty's adjusted earnings per share data for the three months ended in Sep. 2024 was $-1.590. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-3.04 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 28.00% per year. During the past 5 years, the average E10 Growth Rate was 26.90% per year. During the past 10 years, the average E10 Growth Rate was 24.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of XOMA Royalty was 28.90% per year. The lowest was 3.60% per year. And the median was 12.90% per year.

As of today (2025-03-04), XOMA Royalty's current stock price is $21.42. XOMA Royalty's E10 for the quarter that ended in Sep. 2024 was $-3.04. XOMA Royalty's Shiller PE Ratio of today is .


XOMA Royalty E10 Historical Data

The historical data trend for XOMA Royalty's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty E10 Chart

XOMA Royalty Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.16 -11.32 -9.53 -7.25 -4.22

XOMA Royalty Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.50 -4.22 -3.83 -3.32 -3.04

Competitive Comparison of XOMA Royalty's E10

For the Biotechnology subindustry, XOMA Royalty's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XOMA Royalty's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA Royalty's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where XOMA Royalty's Shiller PE Ratio falls into.



XOMA Royalty E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, XOMA Royalty's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-1.59/133.0289*133.0289
=-1.590

Current CPI (Sep. 2024) = 133.0289.

XOMA Royalty Quarterly Data

per share eps CPI Adj_EPS
201412 -2.490 99.070 -3.344
201503 -3.800 99.621 -5.074
201506 -4.000 100.684 -5.285
201509 -0.080 100.392 -0.106
201512 4.330 99.792 5.772
201603 -1.400 100.470 -1.854
201606 -2.520 101.688 -3.297
201609 -2.080 101.861 -2.716
201612 -2.890 101.863 -3.774
201703 -2.370 102.862 -3.065
201706 0.020 103.349 0.026
201709 1.980 104.136 2.529
201712 -0.160 104.011 -0.205
201803 -0.460 105.290 -0.581
201806 -0.230 106.317 -0.288
201809 -0.550 106.507 -0.687
201812 -0.350 105.998 -0.439
201903 0.210 107.251 0.260
201906 -0.470 108.070 -0.579
201909 0.200 108.329 0.246
201912 -0.490 108.420 -0.601
202003 -0.490 108.902 -0.599
202006 -0.330 108.767 -0.404
202009 -0.100 109.815 -0.121
202012 1.320 109.897 1.598
202103 -0.700 111.754 -0.833
202106 -0.310 114.631 -0.360
202109 -0.510 115.734 -0.586
202112 1.670 117.630 1.889
202203 -0.320 121.301 -0.351
202206 -0.530 125.017 -0.564
202209 -0.480 125.227 -0.510
202212 -0.640 125.222 -0.680
202303 -0.980 127.348 -1.024
202306 -0.590 128.729 -0.610
202309 -0.600 129.860 -0.615
202312 -1.870 129.419 -1.922
202403 -0.860 131.776 -0.868
202406 0.840 132.554 0.843
202409 -1.590 133.029 -1.590

Add all the adjusted EPS together and divide 10 will get our e10.


XOMA Royalty  (NAS:XOMA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


XOMA Royalty E10 Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


XOMA Royalty Business Description

Traded in Other Exchanges
Address
2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Executives
Biotechnology Value Fund L P other: See Explanation of Responses 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bradley Sitko officer: Chief Investment Officer C/O XOMA CORPORATION, 2200 POWELL STREET, SUITE 310, EMERYVILLE CA 94608
Thomas M. Burns officer: Chief Financial Officer 2910 SEVENTH STREET, BERKELEY CA 94710
Owen Hughes director, officer: Interim CEO C/O RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, BOSTON MA 02139
James R Neal officer: VP Business Development 2910 SEVENTH STREET, BERKELEY CA 94710
Heather L Franklin director C/O ZYMOGENETICS, INC., 1201 EASTLAKE AVE E, SEATTLE WA 98102
Natasha Hernday director 932 SOUTHWOOD BLVD, INCLINE VILLAGE NV 89451
Bvf Ii Gp Llc 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Gp Holdings Llc 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf I Gp Llc 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Van Ness W Denman director C/O XOMA LTD, 2910 SEVENTH ST., BERKELEY CA 94710
Barbara Kosacz director 3175 HANOVER STREET, PALO ALTO CA 94304
Deepshikha Datta officer: Chief Business Officer 2200 POWELL STREET, SUITE 310, EMERYVILLE CA 94608
John Varian director, officer: Director and CEO ARYX THERAPEUTICS,INC., 6300 DUMBARTON CIRCLE, FREMONT CA 94555
Matthew D Perry director, other: See Explanation of Responses ONE SANSOME STREET, 30TH FLOOR, SAN FRANCISCO CA 94104